| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $1.8M | -10.3% |
| SG&A Expense | $2.3M | -40.1% |
| Operating Income | -$4.5M | +22.9% |
| Interest Expense | $539K | -3.9% |
| Pre-tax Income | $18.9M | +220.3% |
| Net Income | $90.0M | +10.5% |
| EPS (Basic) | $0.02 | +150.0% |
| EPS (Diluted) | $0.02 | +150.0% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.7M | -50.6% |
| Short-term Investments | $24.3M | — |
| Current Assets | $52.0M | -7.1% |
| Total Assets | $52.2M | -7.2% |
| Current Liabilities | $27.2M | -80.0% |
| Long-term Debt | $828K | -34.9% |
| Total Liabilities | $27.3M | -80.0% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.4M | +36.1% |
| Capital Expenditures | $214K | +0.0% |
| Investing Cash Flow | -$24.4M | — |
| Financing Cash Flow | -$490K | -100.8% |
| Free Cash Flow | -$3.6M | +34.8% |
| Stockholders' Equity |
| $24.6M |
| +130.6% |